News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series
Walgreens is heading down a risky path
Walgreens has been attempting a financial turnaround for years, and now it says it’s found a new path to finish it. But if history is any guide, its path is more likely to lead to its eventual demise than long-term success.
Walgreens’ breakup looms as $10 billion sale to go private is reportedly in the works
Drugstore chain Walgreens Boots Alliance Inc. is closing in on a roughly $10 billion deal to sell itself to Sycamore Partners, a private-equity firm, which would then take Walgreens private and likely break it up, according to reports late Monday.
NEWS RELEASE: OptumRx and Walgreens Sued Over the Death of Twenty-Two-Year-Old Who Couldn’t Afford His Asthma Medication
The lawsuit alleges that on January 10, 2024, Cole tried to fill his prescription for Advair Diskus, an asthma inhaler he had taken for many years, but was told that it would cost him $539 out-of-pocket because it was no longer covered by his insurance.
DOJ sues Walgreens, alleging it ‘knowingly’ filled millions of prescriptions that lacked legitimate medical purposes
“This lawsuit seeks to hold Walgreens accountable for the many years that it failed to meet its obligations when dispensing dangerous opioids and other drugs,” said Principal Deputy Assistant Attorney General Brian Boynton, head of the DOJ’s Civil Division.
Walgreens Says It Will Close 1,200 Stores
The pharmacy giant said it would close the stores over the next three years and plans to “redeploy” the majority of the workers at the closed stores.
How Chaos at Chain Pharmacies Is Putting Patients at Risk
Pharmacists across the U.S. warn that the push to do more with less has made medication errors more likely. “I am a danger to the public,” one wrote to a regulator.
Note: This article was last updated on October 13, 2021.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.